Sawai Group (SWPIF) Stock Price, News & Analysis

Company Overview

Sawai Group operates as a pharmaceutical manufacturer primarily focused on the development, production and distribution of generic drugs. Headquartered in Japan, the company has built its reputation on supplying affordable and high-quality pharmaceutical products to meet both domestic and international demand. Through its integrated manufacturing facilities, Sawai Group oversees processes from active pharmaceutical ingredient synthesis to finished dosage form production, ensuring rigorous quality control and regulatory compliance at every stage.

The company’s product portfolio spans a wide range of therapeutic categories, including cardiovascular, anti-infective, central nervous system and gastrointestinal agents, along with over-the-counter remedies. Sawai Group places particular emphasis on research and development aimed at enhancing generic formulations and improving drug delivery systems. Its production network is equipped with state-of-the-art granulation, tablet-pressing and sterile filling lines, enabling efficient scale-up of new products and rapid response to market needs.

While the domestic Japanese market remains Sawai Group’s core focus, the company also exports to select countries in Asia and North America through partnerships and established distribution channels. This international presence supports broader access to affordable medicines in regions where generic penetration continues to grow. Sawai Group maintains compliance with multiple regulatory authorities, including Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and, for exported products, relevant overseas regulatory bodies.

Founded in the late 1960s, Sawai Group has grown through continuous investment in manufacturing capacity and quality assurance systems. The company is governed by a board of directors with expertise in pharmaceutical science, production engineering and global regulatory affairs. Through strategic facility expansions and ongoing R&D efforts, Sawai Group seeks to reinforce its position as a leading generics supplier while contributing to sustainable healthcare cost management worldwide.

Key Stats

• Today's Range: $48.17 to $48.17
• 50-Day Range: $48.17 to $48.17
• 52-Week Range: $104,148.60 to $104,148.60
• Volume: N/A
• Average Volume: 625 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SWPIF
• CIK: N/A
• Web: www.sawai.co.jp
• Phone: (166) 105-5711
• Fax: N/A
• Employees: 3,066
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A